Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases.

Monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH) are two enzymes from the serine hydrolase superfamily that degrade the endocannabinoids 2-arachidonoylglycerol and anandamide, respectively. We have recently discovered that MAGL and FAAH are both inhibited by carbamates bearing an N-piperidine/piperazine group. Piperidine/piperazine carbamates show excellent in vivo activity, raising brain endocannabinoid levels and producing CB1-dependent behavioral effects in mice, suggesting that they represent a promising class of inhibitors for studying the endogenous functions of MAGL and FAAH. Herein, we disclose a full account of the syntheses, structure-activity relationships, and inhibitory activities of piperidine/piperazine carbamates against members of the serine hydrolase family. These scaffolds can be tuned for MAGL-selective or dual MAGL-FAAH inhibition by the attachment of an appropriately substituted bisarylcarbinol or aryloxybenzyl moiety, respectively, on the piperidine/piperazine ring. Modifications to the piperidine/piperazine ring ablated inhibitory activity, suggesting a strict requirement for a six-membered ring to maintain potency.

[1]  J. Ferrer,et al.  Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling , 2010, Chembiochem : a European journal of chemical biology.

[2]  D. Nomura,et al.  Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis , 2010, Cell.

[3]  D. Nomura,et al.  Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo , 2009, Proceedings of the National Academy of Sciences.

[4]  K. Mackie,et al.  Monoacylglycerol Lipase Limits the Duration of Endocannabinoid-Mediated Depolarization-Induced Suppression of Excitation in Autaptic Hippocampal Neurons , 2009, Molecular Pharmacology.

[5]  J. Long,et al.  Blockade of 2-Arachidonoylglycerol Hydrolysis by Selective Monoacylglycerol Lipase Inhibitor 4-Nitrophenyl 4-(Dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances Retrograde Endocannabinoid Signaling , 2009, Journal of Pharmacology and Experimental Therapeutics.

[6]  D. Boger,et al.  Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain , 2009, Journal of Pharmacology and Experimental Therapeutics.

[7]  D. Nomura,et al.  Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism. , 2009, Chemistry & biology.

[8]  J. Long,et al.  Inhibitors of Endocannabinoid-Metabolizing Enzymes Reduce Precipitated Withdrawal Responses in THC-Dependent Mice , 2009, The AAPS Journal.

[9]  R. Stevens,et al.  Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. , 2009, Chemistry & biology.

[10]  Steven J Brown,et al.  Substrate-Free High-Throughput Screening Identifies Selective Inhibitors for Uncharacterized Enzymes , 2009, Nature Biotechnology.

[11]  Sherry L. Niessen,et al.  Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling. , 2008, Bioorganic & medicinal chemistry letters.

[12]  Benjamin F. Cravatt,et al.  Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects , 2008, Nature chemical biology.

[13]  J. Casida,et al.  Organophosphate-sensitive lipases modulate brain lysophospholipids, ether lipids and endocannabinoids. , 2008, Chemico-biological interactions.

[14]  B. Cravatt,et al.  Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. , 2008, Annual review of biochemistry.

[15]  B. Cravatt,et al.  Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. , 2008, Chemical reviews.

[16]  Maurizio Recanatini,et al.  Multi-target-directed ligands to combat neurodegenerative diseases. , 2008, Journal of medicinal chemistry.

[17]  B. Cravatt,et al.  A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol , 2007, Chemistry & biology.

[18]  Marya Liimatta,et al.  Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity. , 2007, Biochemistry.

[19]  B. Cravatt,et al.  A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. , 2007, Journal of the American Chemical Society.

[20]  B. Cravatt,et al.  Mechanism-based profiling of enzyme families. , 2006, Chemical reviews.

[21]  A. Saghatelian,et al.  A FAAH-regulated class of N-acyl taurines that activates TRP ion channels. , 2006, Biochemistry.

[22]  P. Glynn.  A mechanism for organophosphate-induced delayed neuropathy. , 2006, Toxicology letters.

[23]  B. Cravatt,et al.  Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes. , 2005, Chemistry & biology.

[24]  Nasreen S Jessani,et al.  A streamlined platform for high-content functional proteomics of primary human specimens , 2005, Nature Methods.

[25]  R. Desimone,et al.  Privileged structures: applications in drug discovery. , 2004, Combinatorial chemistry & high throughput screening.

[26]  Dale L Boger,et al.  Discovering potent and selective reversible inhibitors of enzymes in complex proteomes , 2003, Nature Biotechnology.

[27]  Raymond C Stevens,et al.  Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling , 2002, Science.

[28]  T. Freund,et al.  Brain monoglyceride lipase participating in endocannabinoid inactivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Burbaum,et al.  Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site‐directed probes , 2001, Proteomics.

[30]  B. Cravatt,et al.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. J. Lusis,et al.  Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene. , 2001, Gene.

[32]  B. Cravatt,et al.  Activity-based protein profiling: the serine hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Julius,et al.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide , 1999, Nature.

[34]  B. Cravatt,et al.  Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties. , 1999, Biochemistry.

[35]  P. Glynn,et al.  Neuropathy target esterase and a homologous Drosophila neurodegeneration-associated mutant protein contain a novel domain conserved from bacteria to man. , 1998, The Biochemical journal.

[36]  U. Hellman,et al.  cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase , 1997, The Journal of Biological Chemistry.

[37]  P. Glynn,et al.  Neuropathy target esterase (NTE) and organophosphorus-induced delayed polyneuropathy (OPIDP): recent advances. , 1995, Toxicology letters.

[38]  M. Johnson,et al.  Synthesis and characterization of a biotinylated organophosphorus ester for detection and affinity purification of a brain serine esterase: neuropathy target esterase. , 1994, Biochemical Journal.

[39]  B. E. Evans,et al.  Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. , 1988, Journal of medicinal chemistry.